Wordt geladen...
Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African Regions
Two HIV-1 subtype C gp120 protein candidates were the selected antigens for several experimental vaccine regimens now under evaluation in HVTN 100 Phase I/II clinical trial aiming to support the start of the HVTN 702 Phase IIb/III trial in southern Africa, which is designed to confirm and extend the...
Bewaard in:
| Gepubliceerd in: | Vaccines (Basel) |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4931634/ https://ncbi.nlm.nih.gov/pubmed/27187483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines4020017 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|